Literature DB >> 8656780

Antimitotic natural products and their interactions with tubulin.

E Hamel1.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8656780     DOI： 10.1002/(SICI)1098-1128(199603)16:2<207::AID-MED4>3.0.CO;2-4

Source DB:  PubMed          Journal:  Med Res Rev        ISSN： 0198-6325            Impact factor:   12.944


× No keyword cloud information.
  38 in total

Review 1.  Antimicrotubular drugs binding to vinca domain of tubulin.

Authors:  Suvroma Gupta; Bhabatarak Bhattacharyya
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

2.  N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a new scaffold that provides rapid access to antimicrotubule agents: synthesis and evaluation of antiproliferative activity against select cancer cell lines.

Authors:  Jonathan A Stefely; Rahul Palchaudhuri; Patricia A Miller; Rebecca J Peterson; Garrett C Moraski; Paul J Hergenrother; Marvin J Miller
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

3.  Microtubule stability studied by three-dimensional molecular theory of solvation.

Authors:  Piotr Drabik; Sergey Gusarov; Andriy Kovalenko
Journal:  Biophys J       Date:  2006-10-20       Impact factor: 4.033

4.  Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model.

Authors:  Bin Zhang; Arpita Maiti; Sharon Shively; Fara Lakhani; Gaye McDonald-Jones; Jennifer Bruce; Edward B Lee; Sharon X Xie; Sonali Joyce; Chi Li; Philip M Toleikis; Virginia M-Y Lee; John Q Trojanowski
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

5.  Hsp70 and thermal pretreatment mitigate developmental damage caused by mitotic poisons in Drosophila.

Authors:  Olga A Isaenko; Timothy L Karr; Martin E Feder
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

6.  In silico design of tubulin-targeted antimitotic peptides.

Authors:  Stefano Pieraccini; Giorgio Saladino; Graziella Cappelletti; Daniele Cartelli; Pierangelo Francescato; Giovanna Speranza; Paolo Manitto; Maurizio Sironi
Journal:  Nat Chem       Date:  2009-10-23       Impact factor: 24.427

Review 7.  Is signal transduction modulated by an interaction between heterotrimeric G-proteins and tubulin?

Authors:  R Ravindra
Journal:  Endocrine       Date:  1997-10       Impact factor: 3.633

Review 8.  Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy.

Authors:  Kinsie E Arnst; Souvik Banerjee; Hao Chen; Shanshan Deng; Dong-Jin Hwang; Wei Li; Duane D Miller
Journal:  Med Res Rev       Date:  2019-02-11       Impact factor: 12.944

9.  Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization.

Authors:  Haichan Niu; Tracy E Strecker; Jeni L Gerberich; James W Campbell; Debabrata Saha; Deboprosad Mondal; Ernest Hamel; David J Chaplin; Ralph P Mason; Mary Lynn Trawick; Kevin G Pinney
Journal:  J Med Chem       Date:  2019-05-24       Impact factor: 7.446

10.  Molecular modelling evaluation of the cytotoxic activity of podophyllotoxin analogues.

Authors:  Md Afroz Alam; Pradeep Kumar Naik
Journal:  J Comput Aided Mol Des       Date:  2008-12-04       Impact factor: 3.686
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.